Aktiesnakken — Juli 2010
-
sjovt bullit point: Leverage board & management team expertise
-
med andre ord: lisa ud. tjek.
-
på forsiden af genmab.com til højre ved meddelelsen
-
hov - fase II i MS kommer "indenfor få uger" - er det ikke nyt?
-
vør opmærksom på at få fat på det rigtige cc... og ikke det fra lisas exit
-
jo
-
og AKA rapporterer også... IR-Live som vælges i dropdown menuen her i chatten. Der hvor der står "dansk
" lige nu -
Genmab costs eliminated but
significant value retained -
Genmab and GSK are fully committed
to develop Ofatumumab -
GEN bruge i hvert fald ikke cash på musikalske stjerner på deres CC
-
så kører vi
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind